Germantown-based Intrexon Corp. a synthetic biology company, plans to raise up to $150 million though a secondary offering of common stock, the company said late Tuesday.
Intrexon (NYSE: XON) was trading at around $29 a share Wednesday.
{iframe}http://www.bizjournals.com/washington/blog/2015/01/germantown-s-intrexon-corp-plans-150m-offering.html{/iframe}